Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Crit Care Med. 2016 Feb;44(2):360–367. doi: 10.1097/CCM.0000000000001572

Table 1.

Selected Baseline Characteristics of the Study Patientsa

Thiamine (n = 43) Placebo (n = 45)
Demographics
 Age – mean years (SD) 70 (14) 65 (17)
 Sex – no. female (%) 17 (40) 19 (42)
 Race – no. white (%) 36 (84) 40 (89)
 BMIb - kg/m2 (SD) 29 (9) 29 (7)
Co-morbidities – No. (%)
 Coronary artery disease 9 (21) 10 (22)
 Congestive heart failure 10 (23) 12 (27)
 Hypertension 24 (56) 22 (49)
 Chronic pulmonary disease 10 (23) 13 (29)
 Diabetes 19 (44) 6 (13)
  Insulin-dependent 5 (12) 5 (11)
 Charlson Comorbidity Indexc – median (quartiles) 2 (1, 3) 3 (1, 5)
Lactate values
 Lactate – median mmol/L (quartiles) 4.1 (2.9, 5.0) 4.1 (3.1, 6.4)
 Lactate > 4 mmol/L – no. (%) 26 (60) 24 (53)
Laboratory values at enrollmentd – median (quartiles)
 White blood count (×103) 13.9 (8.7, 22.5) 13.1 (4.6, 19.3)
 Hemoglobin (g/dL) 10.0 (8.9, 13.0) 10.4 (9.3, 12.5)
 Creatinine (mg/dL) 1.8 (1.0, 2.6) 1.9 (1.4, 3.0)
 Glucose (mg/dL) 145 (91, 191) 136 (116, 191)
Mechanical ventilation and severity of illness
 Mechanical ventilation at time of enrollment – no (%) 31 (74) 30 (67)
 APACHE II score at enrollment – mean (SD) 25.7 (9.1) 26.5 (9.2)
 SOFA score at enrollment – mean (SD) 10.1 (3.7) 10.2 (3.7)
a

SD denotes standard deviation, BMI: body mass index, APACHE II: Acute Physiology and Chronic Health Evaluation II, SOFA: Sequential Organ Failure Assessment score

b

Data missing on 5 patients

c

Data missing on 8 patients

d

Data missing on 6 to 9 patients